Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Establishing a molecular phenotype for Angelman Syndrome stem cell-derived neurons

ABSTRACT: Establishing a molecular phenotype for Angelman Syndrome stem cell-derived neurons

PROVIDER: PRJNA674346 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12973237_1.fastq.gz	Fastqsanger.gz
	SRR12973237_2.fastq.gz	Fastqsanger.gz
	SRR12973238_1.fastq.gz	Fastqsanger.gz
	SRR12973238_2.fastq.gz	Fastqsanger.gz
	SRR12973239_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

Establishing a molecular phenotype for Angelman Syndrome stem cell-derived neurons

Project description:mRNAseq on (1) isogenic control and Angelman Syndrome pluripotent stem cell-derived neurons or (2) antisense oligonucleotide-treated H9 hESC-derived neurons

2021-04-01 | GSE160747 | GEO

Differences in transcription in Angelman syndrome and control person iPSC-derived neurons

Project description:Angelman syndrome is caused by loss of funtional ubiquitin E3 ligase UBE3A and results in severe deley in cognitive and motor development. In neurons, UBE3A locates to the synapse and to the nucleus. Loss of nuclear UBE3A results in development of Angelman syndrome like symptoms in mice. UBE3A can function as transcriptional coactivator of steroid hormone receptors, but the entire function of UBE3A in the nucleus is still not clear. So we wanted to study differences in the transcriptome in neurons differentiated from iPSCs that were derived from patients with Angleman syndrome and normal controls.

2020-12-31 | GSE146640 | GEO

Single nuclei RNA-sequencing of frontal cortex of a pig model of Angelman syndrome

Project description:Angelman syndrome is a neurodevelopmental disorder caused by the loss of the maternal allele of the ubiquitin-protein ligase E3A (UBE3A) gene. UBE3A is imprinted with maternal-allelic expression in neurons of the central nervous syndrome (CNS) and biallelically expressed in other cell types. Consequently, in Angelman syndrome, UBE3A is absent in CNS neurons and reduced by half in other cells. It is unclear how cell type-specific gene expression in the brain is dysregulated in Angelman syndrome. Using single nuclei RNA-sequencing, we show that gene expression is dysregulated in neuronal subtypes in the frontal cortex of neonatal pigs with a UBE3A maternal deletion. A total of 3,812 unique genes were dysregulated across ten cell-type clusters, with most of the dysregulated genes (3,154 genes) in excitatory neurons.

2025-12-23 | GSE314025 | GEO

Persistent neuronal stress signaling underlies Angelman syndrome phenotypes

Project description:Angelman syndrome is a severe neurodevelopmental disorder caused by loss of UBE3A, a gene that encodes an E3 ubiquitin ligase. The mechanisms underlying this disorder are not well understood, and the link between UBE3A substrates and disease phenotypes remains uncertain. Here, we identify asparagine synthetase (ASNS) as a novel target of UBE3A. We find that ASNS protein levels are elevated in brains of Angelman syndrome model mice, and metabolomic analysis revealed these animals possess imbalanced amino acid levels leading to a persistent activation of the integrated stress responseincrease in stress signaling and a global reduction in neuronal protein synthesis. When ASNS levels were genetically reduced in mutant animals, stress signaling and protein synthesis rates were corrected, and many behavioral and neuroanatomical deficits were rescued. Our results suggest that UBE3A operates in neurons to clear stress signaling, and our resultsfurther suggest that ASNS and the integratedthe stress response are potential therapeutic targets in Angelman syndrome.

2026-09-02 | GSE319851 | GEO

Channelopathy pathogenesis in a human neural cell model of Angelman Syndrome

Project description:Angelman syndrome (AS) is a neurogenetic developmental disorder that results from the loss of E3 ubiquitin ligase UBE3A due to mutations in or deletions of the maternally inherited UBE3A allele. While mouse models of AS have implicated abnormal synaptic signaling and plasticity underlying behavioral dysfunction, how the loss of UBE3A contributes to hyperactivity of neuronal networks seen in AS patients remains unclear. Here, by utilizing human induced neurons and 3D cortical organoids derived from AS patient iPSCs and CRISPR-Cas9 mediated UBE3A KO hESCs, we uncovered a novel role of UBE3A in suppressing neuronal hyperexcitability via ubiquitin-mediated degradation of BK channels. More importantly, augmented BK channel activity in neurons manifested as increased intrinsic excitability of neurons and network level bursting and synchronization, which can be pharmacologically normalized by BK antagonists. Our study has illustrated the utility of modeling neurological diseases with human neural cells, and our results have provided new insights into underlying pathophysiological mechanisms and potential therapeutic strategy in Angelman syndrome.

2020-08-18 | GSE120225 | GEO

Differences in transcription in Angelman syndrome and control person iPSC-derived neurons

Project description:Differences in transcription in Angelman syndrome and control person iPSC-derived neurons

| PRJNA611562 | ENA

Angelman syndrome trio

Project description:Exome sequencing Angelman trio

| PRJEB41088 | ENA

Persistent neuronal stress signaling underlies Angelman syndrome phenotypes

Project description:Persistent neuronal stress signaling underlies Angelman syndrome phenotypes

| PRJNA1425309 | ENA

Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader-Willi Syndrome - ARP 5207

Project description:Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader-Willi Syndrome - ARP 5207